No adverse reactions have been reported yet. All lots, flavors, and variations totaling 440+ boxes are affected. Products were sold nationwide online via xdeor.com and maxensupplements.com between November 9, 2025, and March 28, 2026.
Who's At Risk?
Individuals using other medications or substances, people with underlying medical conditions, and frequent users may face an increased risk of severe or fatal health effects.
Symptoms
Consumption of products containing mitragynine or mitragynine pseudoindoxyl (MP) may cause nausea, vomiting, rapid heart rate, palpitations, hallucinations, sedation, anxiety, or loss of consciousness. Severe cases may result in respiratory depression, addiction, and opioid-like withdrawal symptoms.
